跳至主要内容
临床试验/CTRI/2021/12/038889
CTRI/2021/12/038889已完成2 期

RANDOMIZED CONTROLLED CLINICAL TRIAL ON COMBINATION OF BHASKAR GHRITA NASYA AND SAPTAMRITA LAUHA IN MANAGEMENT OF PRATHAMA-DWITIYA PATALGATA TIMIR w.r.t HYPERMETROPIA

Sane Guruji Arogya Kendra0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having symptoms of Prathama Dwitiya Patalgata Timir will be included.
  • 2. Patients who have = +5 D in both the eyes
  • 3. The patient age from 18 years to 60 years of age
  • 4. Patient having vision of 6/9 or less i.e., 6/12, 6/18,6/24, 6/36, 6/60.
  • 5. Patient yogya for Nasya Karma.
  • 6. Patient of either gender will be included in the study.

排除标准

  • 1. Patients having symptoms of Tritiya and Chaturtha Patalgata Timir will be excluded like Kacha and Linganasha.
  • 2. Patient suffering from infectious disease e.g.-viral, bacterial or fungal conjunctivitis, blepharitis and trachoma.
  • 3. Patient having known case of Hypertension, HIV, TB, Rheumatic Heart Disease, Bronchial Asthma, Thyroid disorder.
  • 4. Hypermetropia associated with other ocular disease such as cataract, glaucoma, retinal disease, chorioretinitis, iridocyclitis, choroidal disease, vitreal opacity, cornel opacity, corneal ulcer.
  • 5. Congenital, Acquired non physiological hypermetropia like index hyermetropia, pseudophakic hypermetropia.
  • 6. Refractive errors like astigmatism, myopia, presbyopia and other ocular pathologies will be excluded.

研究者

相似试验